CN Bio opens new laboratory facility in Cambridge to expand Organ-on-a-chip services

CN Bio (Cambridge, UK), a notable Organ-on-a-chip company and single-and multi-organ micro physiological systems manufacturer, has announced the opening of new laboratory facilities at Cambridge Science Park in order to expand its contract research services.

CN Bio has doubled its company’s laboratory space in response to the growing demand within the market for Organ-on-a-chip Company (OOC) services, due to the drug discovery and development programs creating more traction for the technology.

Dr Gareth Guenigault, Lead Scientist of CN Bio’s Contract Research Services, commented:

“This expansion is an exciting next step in the progression of our contract research services offering. As we see increasing awareness within the drug discovery, development and regulatory fields that animal models don’t always get it right, nor are ethically desirable, we are poised to offer solutions that fit researchers’ individual needs. By utilising the power of OOC technology to provide early stage, clinically translatable data across a range of applications, we hope to give customers greater confidence in the success of their projects, in a fraction of the time and cost.”

You may also be interested in:

• Bioanalysis for monitoring the organ-on-a-chip systems
• Worm your way to diagnosis: ‘worm-on-a-chip’ device could be used to diagnose lung cancer
• Expansion of Ardena development and manufacturing site to aid in COVID-19 vaccine development by Novavax

The recognition of OOC data by pharma and biotech companies in their therapeutic programs has led to the rising demand for OOC services. This acceptance is being driven by increased interest from regulatory agencies, continuous business and MPS technology’s potential to replace animal models – particularly when testing new drug modalities with human-specific modes of action – and the capability to foresee clinical outcomes. OOC’s performance is evidently outshining traditional approaches, as the growing pieces of evidence show, the company’s expansion is more than capable of meeting the demands of this growing market.

Source: CN Bio press release: https://cn-bio.com/cn-bio-opens-new-lab-facilities-to-extend-organ-on-a-chip-contract-research/